Norton Rose Fulbright Paris reaches high rankings in Life sciences and healthcare sectors of Décideurs Leaders League 2018 edition:
- Outstanding (Tier 1) – Competition and distribution: Healthcare and pharmaceuticals sector
- Excellent (Tier 2)– Healthcare, pharmaceuticals & biotechnologies: E-Health
- Excellent (Tier 2) – Healthcare, pharmaceuticals and biotechnologies: Regulatory
- Highly recommended (Tier 3) – Healthcare, pharmaceuticals and biotechnologies: Capital, joint venture, and corporate transactions
Notes for editors:
Norton Rose Fulbright is a global law firm providing the world’s preeminent corporations and financial institutions with a full business law service. The firm has more than 4,000 lawyers and other legal staff based in Europe, the United States, Canada, Latin America, Asia, Australia, the Middle East and Africa.
Recognized for its industry focus, Norton Rose Fulbright is strong across all the key industry sectors: financial institutions; energy; infrastructure, mining and commodities; transport; technology and innovation; and life sciences and healthcare. Through its global risk advisory group, the firm leverages its industry experience with its knowledge of legal, regulatory, compliance and governance issues to provide clients with practical solutions to the legal and regulatory risks facing their businesses.
Norton Rose Fulbright operates in accordance with its global business principles of quality, unity and integrity, aiming to provide the highest possible standard of legal service in each of its offices and to maintain that level of quality at every point of contact.
Norton Rose Fulbright Verein, a Swiss verein, helps coordinate the activities of Norton Rose Fulbright members but does not itself provide legal services to clients. Norton Rose Fulbright has offices in more than 50 cities worldwide, including London, Houston, New York, Toronto, Mexico City, Hong Kong, Sydney and Johannesburg.